Cell-specific phosphoproteomes were interrogated in PDA cells expressing either KRASWT or KRASG12D, either in homo- or heteroculture with isotopically “heavy”-labeled PSCs, and treated with either SHH inhibitor or vehicle. Here, SHH is linked to Patent ductus arteriosus.